Jazz Pharmaceuticals Completes $1.25B Exchangeable Senior Notes Offering

What Happened
Jazz Pharmaceuticals plc (through wholly‑owned subsidiary Jazz Investments I Limited) announced on August 31, 2026 that it completed a private offering of $1.25 billion aggregate principal amount of 1.875% exchangeable senior notes due 2032. The Notes were issued under an indenture dated August 31, 2026 and are fully and unconditionally guaranteed by Jazz Pharmaceuticals plc as senior unsecured obligations. The issuer expects net proceeds of approximately $1,226.4 million and intends to use the funds for general corporate purposes. Concurrent with the offering pricing, the company repurchased about $225.0 million of its ordinary shares at $249.29 per share using cash on hand, as part of its ongoing share repurchase program.

Key Details

• Offering size: $1.25 billion principal amount (includes full $150.0M initial purchaser option).
• Coupon & maturity: 1.875% interest, payable semi‑annually; maturity September 15, 2032.
• Net proceeds: ~ $1,226.4 million after fees and expenses.
• Exchange terms: initial exchange rate 2.8150 ordinary shares per $1,000 principal (≈ $355.24 per share); on exchange issuer may deliver cash, ordinary shares, or a mix.
• Concurrent share repurchase: ~ $225.0 million of ordinary shares repurchased at $249.29/share, funded from cash on hand and reducing the remaining authorization under the July 2024 repurchase program.
• Documents: Notes issued under an indenture (Aug 31, 2026); Purchase Agreement entered Aug 26, 2026 with customary indemnities to initial purchasers.

Why It Matters
This transaction changes Jazz’s capital structure by adding $1.25B of senior unsecured exchangeable debt that could, if exchanged, be settled partly in ordinary shares — a potential source of future dilution if holders choose to exchange. The company also used cash to repurchase roughly $225M of ordinary shares, which reduces share count and offsets some dilution. Net proceeds increase Jazz’s available liquidity for corporate purposes; investors should watch for future notices about redemptions, exchange conditions, and any listings of the Notes (issuer intends to seek Bermuda Stock Exchange listing before the first interest date).